13-Oct-21

InterCure to Present in Benzinga Cannabis Capital Conference

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will present at the Benzinga Cannabis Capital Conference
12-Oct-21

InterCure CEO Alex Rabinovitch Purchases Over 420,000 Shares of Company Stock in The Open Market

NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that CEO Alexander Rabinovitch purchased, throughout the month of September 2021, a total of 423,501
03-Sep-21

InterCure Re-Announces its Record-Breaking Second Quarter Financial Results With 4 Times YOY Revenue Growth - Following NASDAQ Listing

Achieved record revenue of NIS 45 million (over CAD$17 million), an increase of 400% year-over-year and 37% quarter-over-quarter Achieved quarterly run-rate Q2 Pro Forma 1 revenues of NIS 55 million (over CAD$21 million) Recorded continued increase in operating profit, EBITDA 2 and net profit
02-Sep-21

InterCure Continuing its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition of Cannomed Pharmacy Chain

Acquisition includes two medical cannabis dispensing pharmaci es , another pharmacy in the process of receiving its license and a medical cannabis patient support center C ompanies will partner in Cannomed online platform dedicated to fulfilling orders of medical cannabis products and in medical
01-Sep-21

InterCure Commences Trading on NASDAQ Under the Symbol “INCR”

The leading cannabis company outside North America debuts today on Nasdaq NEW YORK and TORONTO and HERZLIYA, Israel, Sept. 01, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the “Company”) is pleased to announce the Company’s common shares will
16-Aug-21

InterCure Announces Record-Breaking Second Quarter Financial Results With 4 Times YOY Revenue Growth

InterCure Ltd. (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (the "Company") is pleased to announce its financial results for the second quarter of 2021 and provide a business update. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted.
19-Jul-21

InterCure Advances Towards NASDAQ Listing

Trading expected to begin in the last week of July TORONTO, July 19, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “ Company ”) is pleased to announce that further to its confidential filing with the U.S. Securities and Exchange Commission (the " SEC ") of its
10-Jul-21

InterCure provides an Update on its NASDAQ Listing

Trading on the world's leading stock exchange expected to begin in the last week of July TORONTO and HERZLIYA, Israel, July 10, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd . (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “ Company ”) is pleased to announce that further to its confidential filing with the
20-May-21

InterCure Acquires One of Israel's Leading Active Medical Cannabis Trade Houses & Initiates Special Home Delivery Service in Collaboration With UPS

Acquisition of one of the  leading   active ,  IMCA approved trade houses in Israel expand ing   InterCure's   sales channel,  d istribution ,   d elivery  and  s torage  capacity . As part of the acquisition, two additional pharmacies added  to  Intercure’ s   leading medical focused, pharmacy
17-May-21

InterCure Announces Another Record-Breaking First Quarter Financial Results

InterCure Announces Another Record-Breaking First Quarter Financial Results Toronto, Canada, and Herzliya, Israel – May 17, 2021 – InterCure Ltd . (TSX: INCR:U, TASE: INCR)(dba Canndoc)("I ntercure " or the the “Company”) today reported financial results for the first quarter of 2021.
Displaying 1 - 10 of 29